A5053541125- Lymphoma Diagnosis and Treatment
- Cutaneous lymphoproliferative disorders research
- CAR-T cell therapy research
- CNS Lymphoma Diagnosis and Treatment
- Platelet Disorders and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- T-cell and Retrovirus Studies
- Kruppel-like factors research
- Vascular Tumors and Angiosarcomas
- Eosinophilic Disorders and Syndromes
ChiangRai Prachanukroh Hospital
2019-2023
Chiang Mai University
2017-2022
Background: The prognosis and management of primary thrombocytosis (PT) secondary (ST) are different. This study aims to evaluate the role platelet function tests by light transmission aggregometry (LTA), plasma von Willebrand factor antigen (vWF:Ag), ristocetin cofactor activity (vWF:RCo) inflammatory markers [erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)] for differentiation between PT ST. Methods: prospective was carried out in patients with counts greater than 450 x...
Treatments of patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) represent an unmet clinical need. Polatuzumab vedotin (Pola), anti-CD79b antibody-drug-conjugate (ADC), combined bendamustine-rituximab (BR), has recently been approved for these patients. However, there were limited data on real-life studies in R/R DLBCL, especially Thailand. DLBCL who received Pola-based regimens as a salvage treatment between 1 April 2021 and 30 March 2022 from the nationwide...
Background: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare form of cytotoxic lymphoma, characterized by primary cutaneous tissue involvement mimicking inflammatory panniculitis. Treatment for this disease still under debated between conventional chemotherapy or immunosuppressive agents like cyclosporin and prednisolone. Material Methods: A multicenter retrospective study was conducted among adult patients who diagnosed as subcutaneous from January 2013 to December 2020, in...